BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 38533153)

  • 1. Analysis of Evusheld safety and efficacy in multiple sclerosis patients.
    Liu EN; Real M; Yang JH; Fair A; Whitmire N; Perez A; Wilder C; Rosengren S; Kinkel RP; Graves JS
    Mult Scler Relat Disord; 2024 Jun; 88():105733. PubMed ID: 38901372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing the consequences of COVID-19 vaccination between central nervous system (CNS) demyelinating diseases and other neurological disorders.
    Yazdan Panah M; Vaheb S; Mokary Y; Afshari-Safavi A; Shaygannejad A; Ebrahimi N; Shaygannejad V; Mirmosayyeb O
    Vaccine; 2024 Jun; ():. PubMed ID: 38886142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is There a Correlation Between Periodontal Disease Symptoms and the COVID-19 Vaccination?
    AlHazmi B; Natto ZS; AlQarni M
    Cureus; 2024 Apr; 16(4):e58892. PubMed ID: 38800223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicentric observational study of the possible side effects of the COVID-19 vaccine in relation to absorbable thread insertion.
    Poleva I; Szomolai E; Hegedus B; Zhukova O
    J Cutan Aesthet Surg; 2024; 17(2):100-104. PubMed ID: 38800814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI Findings in Case of Post-COVID-19 Vaccination Rhabdomyolysis: A Rare Postvaccination Adverse Effect.
    Kalekar TM; Jaipuria RK; Navani RS
    Indian J Radiol Imaging; 2022 Jun; 32(2):256-259. PubMed ID: 35924123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major severe acute respiratory coronavirus-2 (SARS-CoV-2) vaccine-associated adverse effects; benefits outweigh the risks.
    Esmaeilzadeh A; Maleki AJ; Moradi A; Siahmansouri A; Yavari MJ; Karami P; Elahi R
    Expert Rev Vaccines; 2022 Oct; 21(10):1377-1394. PubMed ID: 35986451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Safety Profile of Common COVID-19 Vaccines in Patients With Multiple Sclerosis.
    Aladdin YS; Alqarni DA; Alamoudi SW; Alharbi AA; Fudhah WA; Alghamdi G; Attar A
    Cureus; 2024 Feb; 16(2):e54852. PubMed ID: 38533153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 vaccination in people with multiple sclerosis, real-life experience.
    Alroughani R; Al-Hashel J; Abokalawa F; AlMojel M; Farouk Ahmed S
    Clin Neurol Neurosurg; 2022 Sep; 220():107374. PubMed ID: 35961255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 Vaccination Reactogenicity in Persons With Multiple Sclerosis.
    Briggs FBS; Mateen FJ; Schmidt H; Currie KM; Siefers HM; Crouthamel S; Bebo BF; Fiol J; Racke MK; O'Connor KC; Kolaczkowski LG; Klein P; Loud S; McBurney RN
    Neurol Neuroimmunol Neuroinflamm; 2022 Jan; 9(1):. PubMed ID: 34753828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study.
    Menni C; May A; Polidori L; Louca P; Wolf J; Capdevila J; Hu C; Ourselin S; Steves CJ; Valdes AM; Spector TD
    Lancet Infect Dis; 2022 Jul; 22(7):1002-1010. PubMed ID: 35405090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse Effects of Pfizer (BioNTech), Oxford-AstraZeneca (ChAdOx1 CoV-19), and Moderna COVID-19 Vaccines among the Adult Population in Saudi Arabia: A Cross-Sectional Study.
    Aldali J; Meo SA; Al-Khlaiwi T
    Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optic Neuritis Following the BNT162b2 mRNA COVID-19 Vaccine in a Patient with Systemic Lupus Erythematosus Uncovering the Diagnosis of Neuromyelitis Optica Spectrum Disorders.
    Shirah B; Mulla I; Aladdin Y
    Ocul Immunol Inflamm; 2023 Aug; 31(6):1213-1215. PubMed ID: 35849732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reported Adverse Effects and Attitudes among Arab Populations Following COVID-19 Vaccination: A Large-Scale Multinational Study Implementing Machine Learning Tools in Predicting Post-Vaccination Adverse Effects Based on Predisposing Factors.
    Hatmal MM; Al-Hatamleh MAI; Olaimat AN; Mohamud R; Fawaz M; Kateeb ET; Alkhairy OK; Tayyem R; Lounis M; Al-Raeei M; Dana RK; Al-Ameer HJ; Taha MO; Bindayna KM
    Vaccines (Basel); 2022 Feb; 10(3):. PubMed ID: 35334998
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.